MEGRX
Price
$168.57
Change
-$2.43 (-1.42%)
Updated
Jun 13 closing price
Net Assets
45.44B
RGAGX
Price
$78.43
Change
-$0.94 (-1.18%)
Updated
Jun 13 closing price
Net Assets
306.22B
Interact to see
Advertisement

MEGRX vs RGAGX

Header iconMEGRX vs RGAGX Comparison
Open Charts MEGRX vs RGAGXBanner chart's image
MFS Growth R2
Price$168.57
Change-$2.43 (-1.42%)
VolumeN/A
Net Assets45.44B
American Funds Growth Fund of Amer R6
Price$78.43
Change-$0.94 (-1.18%)
VolumeN/A
Net Assets306.22B
MEGRX vs RGAGX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MEGRX vs. RGAGX commentary
Jun 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MEGRX is a Buy and RGAGX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGAGX has more cash in the bank: 306B vs. MEGRX (45.4B). RGAGX pays higher dividends than MEGRX: RGAGX (0.65) vs MEGRX (0.00). MEGRX was incepted earlier than RGAGX: MEGRX (22 years) vs RGAGX (16 years). MEGRX (1.09) is less costly to investors than RGAGX (0.30). MEGRX is a more actively managed with annual turnover of: 33.00 vs. RGAGX (25.00). MEGRX has a lower initial minimum investment than RGAGX: MEGRX (0) vs RGAGX (250). RGAGX annual gain was more profitable for investors over the last year : 7.67 vs. MEGRX (-5.23). RGAGX return over 5 years is better than : 51.11 vs. MEGRX (43.11).
MEGRXRGAGXMEGRX / RGAGX
Total Expense Ratio1.080.30360%
Annual Report Gross Expense Ratio1.090.30363%
Fund Existence22 years16 years-
Gain YTD1.7755.20534%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets45.4B306B15%
Annual Yield % from dividends0.000.65-
Returns for 1 year-5.237.67-68%
Returns for 3 years46.5454.6685%
Returns for 5 years43.1151.1184%
Returns for 10 years146.9975.62194%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NBIX124.39-0.62
-0.50%
Neurocrine Biosciences
NMIH40.34-0.26
-0.64%
NMI Holdings
PMCB1.01-0.01
-0.99%
PharmaCyte Biotech
GSBC55.62-1.83
-3.19%
Great Southern Bancorp
CXDO5.14-0.36
-6.55%
Crexendo